Prices as of 2026-11-13 16:20:46 ET
Ticker Appearances
Signal From Noise
Beyond Pharmaceuticals – How AI Is Changing Patient Care
This issue, we close out our three-part _Signal From Noise_ series into the deployment of AI into health care. The first two installments were devoted...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
SPX and QQQ inch closer to Triangle breakouts as Defensive groups falter
US EQUITY TRENDS REMAIN BULLISH, AND TUESDAY'S ADVANCE CARRIED ^SPX -0.86% AND QQQ -1.97% A BIT CLOSER TO BREAKING OUT OF THE TRIANGLE CONSOLIDATION THAT BOTH HAVE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
This report is accessible to Fundstrat Pro, Fundstrat Macro & Fundstrat Weekly memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Signal From Noise
Beyond Pharmaceuticals – How AI Is Changing Patient Care
This issue, we close out our three-part _Signal From Noise_ series into the deployment of AI into health care. The first two installments were devoted...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
SPX and QQQ inch closer to Triangle breakouts as Defensive groups falter
US EQUITY TRENDS REMAIN BULLISH, AND TUESDAY'S ADVANCE CARRIED ^SPX -0.86% AND QQQ -1.97% A BIT CLOSER TO BREAKING OUT OF THE TRIANGLE CONSOLIDATION THAT BOTH HAVE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
This report is accessible to Fundstrat Pro, Fundstrat Macro & Fundstrat Weekly memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
SPX and QQQ inch closer to Triangle breakouts as Defensive groups falter
US EQUITY TRENDS REMAIN BULLISH, AND TUESDAY'S ADVANCE CARRIED ^SPX -0.86% AND QQQ -1.97% A BIT CLOSER TO BREAKING OUT OF THE TRIANGLE CONSOLIDATION THAT BOTH HAVE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
